Related Experiment Videos
Cancer chemoprevention trials
O W Brawley1, P H Phillips, B D Cheson
1National Cancer Institute.
Oncology (Williston Park, N.Y.)
|March 1, 1996
Summary
This resource helps oncologists find suitable cancer clinical trials for patients, aiming to increase participation. Early identification of trials addressing key questions can accelerate therapeutic advancements.
Area of Science:
- Oncology
- Clinical Trials
- Cancer Research
Background:
- Less than 10% of eligible adult patients in the U.S. are enrolled in clinical trials.
- Low accrual rates delay answers to critical therapeutic and scientific questions.
- This impacts the timely dissemination of cancer treatment advances.
Framework:
- The Clinical Trials Referral Resource provides oncologists with a reference for patient-suitable trials.
- Trials selected address important research questions and are not closing soon.
- Eligibility criteria rely on widely available staging and laboratory tests.
Implementation:
- The resource aims to enhance clinical trial accrual by informing practicing oncologists.
- Information on additional protocols is available through Physician's Data Query (PDQ).
- This initiative encourages patient referrals to clinical trials, not cooperative group recruitment.
Implications:
- Facilitating trial identification can expedite answering key oncological questions.
- Increased participation in cancer chemoprevention trials can lead to faster therapeutic progress.
- The program supports evidence-based cancer care by promoting access to novel treatments.